Navigation Links
Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer
Date:12/12/2011

omising collaborative approach."

 

Glioblastoma multiforme, also known as glioblastoma or grade IV astrocytoma, is a fast growing brain tumor that forms from glial (supportive) tissue of the brain.  GBM is the most prevalent form of primary brain tumor and peak incidence is in adults between 45 and 70 years.  Treatment options are limited and survival is little over one year. GBM is considered a rare, or orphan, disease with an incidence in the U.S. of approximately 12,000 per year.

 

Regulus is advancing multiple microRNA therapeutic programs to the clinic in the areas of fibrosis, HCV infection, immuno-inflammatory disease, metabolic disease, and oncology.

 

About microRNAs

The discovery of microRNA in humans during the last decade is one of the most exciting scientific breakthroughs in recent history. microRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. More than 700 microRNAs have been identified in the human genome, and over one-third of all human genes are believed to be regulated by microRNAs. A single microRNA can regulate entire networks of genes. As such, these molecules are considered master regulators of the human genome. microRNAs have been shown to play an integral role in numerous biological processes, including the immune response, cell-cycle control, metabolism, viral replication, stem cell differentiation and human development. Most microRNAs are conserved across multiple species, indicating the evolutionary importance of these molecules as modulators of critical biological pathways. Indeed, microRNA expression, or function, has been shown to be significantly altered in many disease states, including cancer, heart failure and viral infections. Targeting microRNAs with anti-miRs, antisense oligonucleotide inhibitors of mic
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
2. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
3. Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
4. Webinar Advisory: Regulus to Host Discussion About Potential of microRNA-33 as Target for Treatment of Atherosclerosis
5. Regulus Therapeutics Expands Worldwide Patent Coverage on microRNA-122 to Treat Hepatitis C Virus (HCV) Infection
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... its operating results for the second quarter of fiscal ... company will hold a conference call to discuss its ... parties, at 1:30 p.m., Pacific Daylight Time (4:30 p.m., ...
(Date:7/21/2014)... 2014  EHE International, the recognized leader in preventive ... network, today announced that Dignity Health Medical Group Nevada, ... has been named an EHE-certified preventive care center. Through ... region now have greater access to EHE,s ... "EHE is proud to add Dignity ...
(Date:7/21/2014)... , July 21, 2014 /PRNewswire-iReach/ -- Top ... GPM Pediatrics responds to an article, which suggests that ... Logo - http://photos.prnewswire.com/prnh/20140718/128611 ... about giving coffee to children, but now it happens ... . A new study, published in the journal Pediatrics, ...
Breaking Medicine Technology:Thoratec Schedules Second Quarter Conference Call, Webcast 2EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2Dr. Michael Gabriel a Brooklyn Pediatrician Comments on an Article, Which Suggests Caffeine May Be Dangerous for Children 2
... Leading orthopaedic surgeon Simon Moyes has launched a ... from the surgeon,s viewpoint and from inside the joint. ... kind, has been developed by Simon Moyes along ... devices, and is aimed at students, junior surgeons and patients ...
... Jan. 11, 2012  SuccessEHS announces that its newest release ... times when compared to previous releases.  The company has ... Record (EHR) and Practice Management software solution ... The upcoming release will focus on user efficiency and ...
Cached Medicine Technology:Simon Moyes Pioneers New Keyhole Surgery Website 2Newest SuccessEHS Release to Increase Physician Software Usability 2Newest SuccessEHS Release to Increase Physician Software Usability 3
(Date:7/21/2014)... Cannabis Now Magazine recently announced that ... summer. During these festivals, they will strengthen their relationship ... resources to attendees in an effort to continue their ... legitimate and beneficial side of cannabis. , The publication ... the Kush Expo in Anaheim, the Champs Trade Show ...
(Date:7/21/2014)... NY (PRWEB) July 21, 2014 The ... (“League”) and 1199SEIU United Healthcare Workers East (“1199SEIU”) today ... addresses critical issues facing healthcare providers and their employees. ... which will require ratification by League and 1199SEIU members, ... years. In addition, all existing worker benefits, including healthcare ...
(Date:7/21/2014)... human nature to hate losing. , Unfortunately, it,s ... abandoning a solid strategy and thus increasing your chances ... conclusion of a Brigham Young University study published this ... finding is based on an analysis of two decades ... focused on whether coaches adjusted their personnel following games ...
(Date:7/21/2014)... 21, 2014 Ticket Down is ... at the Sun Life Stadium in Miami Gardens, Florida ... between Brazil and Argentina is one that has been going ... rivalries are forming with each passing day. One rivalry that ... Brazil and another South American nation, Colombia. The two teams ...
(Date:7/21/2014)... that HIV and its monkey equivalent, SIV, gain a ... making it difficult to completely eliminate the virus even ... report that SIV can become entrenched in tissues fewer ... detectable in blood plasma (the liquid part) or blood ... Ph.D., of Beth Israel Deaconess Medical Center and the ...
Breaking Medicine News(10 mins):Health News:Cannabis Now Magazine Hits the Marijuana Festival Circuit and Sponsors Two Major Events 2Health News:League of Voluntary Hospitals and Homes and 1199SEIU Reach New Four-Year Collective Bargaining Agreement 2Health News:League of Voluntary Hospitals and Homes and 1199SEIU Reach New Four-Year Collective Bargaining Agreement 3Health News:'Moral victories' might spare you from losing again 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Reports Huge Demand for Colombia vs. Brazil Tickets at Sun Life Stadium in Miami in Early September 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Reports Huge Demand for Colombia vs. Brazil Tickets at Sun Life Stadium in Miami in Early September 3Health News:NIH-supported scientists demonstrate very early formation of SIV reservoir 2
... propose alternative that won,t burden patients, workers, ... Inc., which filed for bankruptcy protection in December, ... workers to ease its continued,financial troubles. However, caregivers ... care. At a rally, workers will unveil their ...
... Healthation CEO Scott Kornhauser,announced the appointment of ... today. Mr. Hebert was a former consulting partner ... complex solutions in the healthcare,industry., Mr. Hebert,s ... and growing market share for Healthation. Prior to,joining ...
... price to the regional, state, or ... nationwide averages, ... on their website, http://www.alijor.com . Users can now view,price summaries ... Provider" feature, patients can compare prices for,consultations, appointments, and follow up ...
... A compound found in grape seed extract reduces plaque ... of Alzheimer,s disease, new research shows. The study appears ... of Neuroscience . , Lead study author Giulio ... and colleagues found that the grape seed extract prevents ...
... cut body fat for those at risk of insulin resistance ... metformin slows the onset of early puberty and reduces the ... conditions, a Spanish study concludes. , "The findings indicate ... when puberty is faster in girls, the appearance of menses ...
... ROCHESTER, Minn., June 17 Researchers have,long suspected ... might affect survival rates following heart attack. In ... researchers present new data,suggesting that people with lower ... after heart attack than more affluent, educated people. ...
Cached Medicine News:Health News:Hospital Workers Say Concessions Will Diminish Patient Care 2Health News:Study indicates grape seed extract may reduce cognitive decline associated with Alzheimer's disease 2Health News:Study indicates grape seed extract may reduce cognitive decline associated with Alzheimer's disease 3Health News:Diabetes Drug May Prevent Early Puberty in Young Girls 2Health News:People With Lower Incomes, Lower Education Levels Have Higher Death Rates After Experiencing Heart Attack 2Health News:People With Lower Incomes, Lower Education Levels Have Higher Death Rates After Experiencing Heart Attack 3
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
... of foldable intraocular lenses. The instrument consists ... under the implant and divides the implant ... support both halves of the lens so ... the anterior chamber is avoided. The instrument ...
Shafts angled 8 mm from tip to bend with smooth jaws. Flat, cross action handle with holes and dull finish....
Bi-angled insertion jaws designed to enhance surgeon comfort and efficiency. Reverse action releases lens when handle is compressed. Made in titanium....
Medicine Products: